Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

PHSYX vs LHCOX overlap: 52% of top holdings shared

Bottom line

How much do PHSYX and LHCOX overlap?

52% of their top holdings overlap by weight. 10 securities appear in both funds' top 25, making up 53.0% of PHSYX's assets and 40.1% of LHCOX's. They share a meaningful core but differ in the rest of the portfolio.

Updated Nov 22, 2026

Overlap at a glance

PHSYXLHCOX
Weight overlap (top 25)52%
Shared holdings10
Weight in shared holdings53.0%40.1%
Total positions11561
Expense ratio0.79%0.68%
Holdings as ofMay 31, 2026Jul 31, 2026

Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)

Holdings PHSYX and LHCOX have in common

Holding% of PHSYX% of LHCOXOverlap
Eli Lilly & Co.13.15%10.40%10.40%
Johnson & Johnson8.46%4.96%4.96%
UnitedHealth Group, Inc.6.93%5.39%5.39%
Novartis AG5.13%4.19%4.19%
AstraZeneca plc4.67%1.97%1.97%
Thermo Fisher Scientific, Inc.4.50%2.31%2.31%
Edwards Lifesciences Corp.2.80%1.78%1.78%
CVS Health Corp.2.74%3.33%2.74%
Gilead Sciences, Inc.2.63%3.53%2.63%
Vertex Pharmaceuticals, Inc.1.97%2.24%1.97%

Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in PHSYX

  1. AbbVie, Inc. — 6.05%
  2. Merck & Co., Inc. — 4.88%
  3. Intuitive Surgical, Inc. — 4.04%
  4. Sanofi SA — 3.23%
  5. Roche Holding AG — 2.79%
  6. McKesson Corp. — 2.14%
  7. Cardinal Health, Inc. — 2.12%
  8. Novo Nordisk A/S — 1.90%
  9. Boston Scientific Corp. — 1.80%
  10. Bristol-Myers Squibb Co. — 1.75%
  11. Dexcom, Inc. — 1.64%
  12. Hoya Corp. — 1.52%
  13. Putnam Short Term Investment Fund — 1.35%
  14. HCA Healthcare, Inc. — 1.18%
  15. Amgen, Inc. — 1.11%

Only in LHCOX

  1. Natera Inc — 3.60%
  2. Guardant Health Inc — 2.61%
  3. Galderma Group AG — 2.60%
  4. Cogent Biosciences Inc — 2.27%
  5. 10X Genomics Inc — 2.16%
  6. BeOne Medicines Ltd — 2.06%
  7. Ascendis Pharma A/S — 1.99%
  8. Madrigal Pharmaceuticals Inc — 1.91%
  9. Bridgebio Pharma Inc — 1.84%
  10. Revolution Medicines Inc — 1.67%
  11. Arrowhead Pharmaceuticals Inc — 1.52%
  12. Protagonist Therapeutics Inc — 1.44%
  13. Dianthus Therapeutics Inc — 1.44%
  14. Adaptive Biotechnologies Corp — 1.42%
  15. Illumina Inc — 1.42%

Asset mix

Asset typePHSYXLHCOX
Stocks98.2%98.2%
Other1.4%—
Repurchase agreements—1.2%
Cash & short-term funds0.6%0.8%

Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)

Country mix

CountryPHSYXLHCOX
US76.2%78.5%
CH7.9%8.8%
GB6.4%2.0%
FR3.2%0.5%
DK2.4%2.0%
JP2.4%1.2%
NL1.2%2.2%
BE—1.4%

Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)

Check another pair

FAQ

How much do PHSYX and LHCOX overlap?
About 52% by weight. 10 securities appear in both funds' top 25 holdings; they make up 53.0% of PHSYX's assets and 40.1% of LHCOX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do PHSYX and LHCOX have in common?
The largest shared holdings are Eli Lilly & Co., UnitedHealth Group, Inc., Johnson & Johnson, Novartis AG, CVS Health Corp..
Should I own both PHSYX and LHCOX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, PHSYX or LHCOX?
PHSYX is broader, with 115 positions versus 61 for LHCOX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.